Revolution Medicines: Funding, Investors & Team (Oct 2026)
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.
Revolution Medicines has raised $1.0B across 2 funding rounds on record, the most recent an undisclosed round of $750M announced in Dec 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Revolution Medicines Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Revolution Medicines Funding Rounds
Revolution Medicines raised $265M in a Post-IPO Equity announced in Jul 2022.
2.4 years later, an undisclosed round of $750M was announced in Dec 2024.
Revolution Medicines Founders and Leadership Team
Contact details for the Revolution Medicines team: 1 of 1 has an email address on file.
Start 14-day free trial →Revolution Medicines Funding Compared to Other Biotechnology Startups
Revolution Medicines' latest round of $750M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Revolution Medicines in Biotechnology and Redwood City
Companies Similar to Revolution Medicines
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Revolution Medicines Funding FAQs
What does Revolution Medicines do?
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.
How much funding has Revolution Medicines raised?
Revolution Medicines has raised $1.0B across 2 rounds on record. The most recent is an undisclosed round of $750M announced in Dec 2024.
When did Revolution Medicines last raise funding?
Revolution Medicines' most recent funding round on record is an undisclosed round of $750M, announced in Dec 2024.
Who founded Revolution Medicines?
FundedIQ lists Martin D Burke (Founder) at Revolution Medicines.
Where is Revolution Medicines headquartered?
Revolution Medicines is based in Redwood City, California, United States.
How many employees does Revolution Medicines have?
Revolution Medicines is in the 251-500 employee band.
How does Revolution Medicines' funding compare to other Biotechnology startups?
Revolution Medicines' latest round of $750M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Revolution Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Revolution Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.